Bing

SEARCH HISTORY

Allos Therapeutics, Inc. (ALTH) will visit the NASDAQ MarketSite in New York City's Times Square. In honor of the occasion and in honor of patients with blood cancers and their families, Dr. Charles Morris, Chief Medical Officer of Allos Therapeutics, Inc ...
NBC News · 10/4/2010
In early April, ALTH closed a public offering with UBS as the underwriter (with an option granted to purchase an additional 1.2M shares at the public offering price through the end of April) for the sale of 7.75 million shares of common stock at price of $ ...
Seeking Alpha · ByMike Havrilla · 4/27/2009
Under the terms of the agreement, Allos Therapeutics stockholders will receive a fixed ratio of 0.1282 shares of AMAG common stock for each share of Allos Therapeutics/ALTH common stock held. The deal values Allos Therapeutics stock at $2.44 a share …
Business Wire · 7/20/2011
DALLAS, Dec. 8, 2009 (GLOBE NEWSWIRE) -- StockPreacher.com announces an investment report featuring Allos Therapeutics Inc. (Nasdaq:ALTH). The report includes financial and investment analysis, analyst consensus, and pertinent industry …
GlobeNewswire · 12/8/2009
We see limited upside potential until Allos is successful in expanding its product portfolio. The stock carries a Zacks #3 Rank (Hold rating) in the short-run.
ZACKS · 2/6/2012
Sales of the drug could reach $300 million in the US, but even if the final tally’s only $150 million, that still adds up to about $5 a share for the stock. And ALTH closed Thursday at $5.89. The stock took a hit as a result of Allos’ Oct. 7 secondary ...
CNBC · 11/5/2009
put open interest at 2,704 contracts (Put/Call ratio at 0.25). Short float at 11.41%, which implies a short ratio of 7.14 days. The stock has lost -10.89% over the last year. 10. Allos Therapeutics, Inc. (ALTH): Drug Manufacturers - Other Industry.
NASDAQ · 2/14/2011
c ) N a m e o f o ffe ro r/o ffe re e in re la tio n to w h o s e re le v a n t s e c u ritie s th is fo rm re la te s : Use a se p arate form for e ach offe ror/offe re e Offe ro r: S yne rg y He alth Plc (GB0 ... of any op e n stock-se ttle d de rivative ...
4 Traders · 8/19/2015
The stock is trading 13% above its 50-day moving average and 12.1% above its 200-day moving average. Trading with a volume of 4.4 million, or 5.5 times its average daily volume, Allos Therapeutics (ALTH) is up on high volume today. At $1.83, the stock ...
Fox Business · 8/29/2012
Shares of Good Times Restaurants Inc. increased by 34.98 percent Friday — a gain unmatched by any other Colorado stock. GTIM ended up 71 cents and ... Allos Therapeutics Inc. (ALTH): down 0.56 percent, or a penny, to $1.78.
The Business Journal · 6/15/2012